News Image

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

Provided By GlobeNewswire

Last update: Mar 11, 2025

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, effective March 11, 2025 (the “Effective Date”). In addition, Matthew Wikler, M.D., and Natasha Giordano stepped down from the Board on the Effective Date.

Read more at globenewswire.com

MATINAS BIOPHARMA HOLDINGS I

NYSEARCA:MTNB (7/25/2025, 8:08:33 PM)

After market: 0.92 -0.01 (-1.09%)

0.9301

-0.02 (-2.09%)



Find more stocks in the Stock Screener

Follow ChartMill for more